The transplant recipient in the emergency department: infection, drug toxicity and rejection
- Approach to a complaint
In a transplant patient, fever, diarrhoea or a rising creatinine can be infection, drug toxicity or rejection, and all three look alike at first.
What it is
Solid-organ transplant recipients take lifelong immunosuppression, usually a calcineurin inhibitor (tacrolimus or ciclosporin) with an antiproliferative drug and a corticosteroid. In the emergency department their problems are infection, drug toxicity or interactions, rejection and surgical complications, often with a blunted fever.
Red flags
- Fever, rigors or low blood pressure, with or without an obvious focus.
- Dry cough, breathlessness or falling saturation on walking (Pneumocystis, CMV, rejection of a lung).
- Diarrhoea or vomiting: dehydration and missed doses swing the drug level both ways.
- Rising creatinine, less urine, or pain over a kidney graft in the iliac fossa.
- Tremor, headache, confusion, seizures or visual change (drug toxicity, posterior reversible encephalopathy, brain infection).
- A new drug started elsewhere in recent days, or doses missed.
Step-by-step approach
- ABCDE and sepsis screen; start antibiotics on suspicion — immunosuppression blunts fever, pus and peritonism.
- Ask the organ, the date of transplant, the immunosuppressants and any new drug — the date predicts the infection, the drugs the toxicity.
- Blood, urine and line cultures, chest X-ray, and CMV testing when the timing fits — cultures before antibiotics give the best yield.
- Calcineurin inhibitor trough level, creatinine, potassium, magnesium and glucose — toxicity and rejection both raise creatinine.
- Check every interaction before prescribing; avoid anti-inflammatories and nephrotoxins — macrolides and azoles can make the level toxic in days.
- Keep immunosuppressants going unless the transplant team advises otherwise; think of steroid cover in shock — missed doses invite rejection.
- Image the graft: Doppler ultrasound for a kidney or liver, CT for a lung — obstruction, collections and clotted vessels mimic rejection.
- Call the transplant team early for any graft dysfunction — rejection is confirmed by biopsy and treated by them.
Infection, drug toxicity or rejection
| Feature | Infection | Calcineurin inhibitor toxicity | Rejection |
|---|---|---|---|
| Typical clue | Fever (may be absent), a focus, raised inflammatory markers | Tremor, headache, high potassium and blood pressure, a new interacting drug | Graft dysfunction, sometimes fever or graft tenderness, missed doses |
| Creatinine | May rise with sepsis or dehydration | Rises; improves when the level falls | Rises in a kidney graft |
| Drug level | Variable; diarrhoea can raise it | High | Often low (missed doses, an inducing drug) |
| Confirming test | Cultures, imaging, CMV PCR | Trough level | Biopsy by the transplant team |
| First action | Antibiotics within the hour | Stop the culprit drug; adjust the dose with the team | Transplant team the same day |
Keys to the differential
- First month: wound, line, urinary and hospital pneumonia, C. difficile, and infections carried in the donor organ.
- One to six months: CMV (fever, low white cells, hepatitis, colitis), Pneumocystis, Listeria, Nocardia, fungi, and reactivated tuberculosis or Chagas disease.
- After six months: community pneumonia and urinary infections, but late CMV and fungi when immunosuppression was increased to treat rejection.
- Headache, confusion and seizures with high blood pressure may be posterior reversible encephalopathy from the calcineurin inhibitor: MRI and the transplant team.
- Skin cancers and post-transplant lymphoma grow faster under immunosuppression: a new mass or lymph node is not dismissed.
Next step
- Blood and urine cultures, blood count, C-reactive protein, lactate and chest X-ray; CMV PCR when the timing fits.
- Calcineurin inhibitor trough level, creatinine, potassium, magnesium, glucose and liver tests.
- Doppler ultrasound of an abdominal graft; chest CT for a lung recipient or an unexplained infiltrate.
- Call the transplant team before changing any immunosuppressant or starting an interacting drug.
- Low threshold to admit; discharge only with the team's agreement, clear return advice and a level check arranged.
Common traps
- No fever means no infection: steroids and immunosuppressants blunt fever; treat the unwell transplant patient as septic.
- Stop the immunosuppressants while the patient is septic: stopping them alone risks rejection; adjust doses only with the transplant team.
- A rising creatinine in a kidney graft is rejection: it may be drug toxicity, dehydration, obstruction or infection; check the level and scan the graft.
- A short course of clarithromycin or fluconazole is harmless: both block CYP3A4 and can push the calcineurin inhibitor to toxic levels within days.
- Any vaccine that is due can be given: live vaccines (yellow fever, measles-mumps-rubella, varicella, oral polio) are contraindicated; inactivated ones such as tetanus are safe.
Test yourself
Think of the answer, then tap the question to see it.
Six weeks after a kidney transplant a man has fever, low white cells and raised liver enzymes. Which infection fits the timing?
CMV, the classic opportunistic infection of the first six months. Send CMV PCR, cultures and liver tests and involve the transplant team, who guide antiviral treatment.
A liver recipient on tacrolimus was given clarithromycin for bronchitis and now has tremor and a rising creatinine. Why?
Clarithromycin inhibits CYP3A4, so the tacrolimus level rises to toxic values. Stop it, check the trough level, adjust with the team and choose an antibiotic that does not interact.
Why can vomiting and diarrhoea in a kidney transplant patient lead to both rejection and drug toxicity?
Vomiting means missed doses and low levels (rejection), while diarrhoea can raise tacrolimus absorption and dehydration injures the kidney (toxicity). Check the level and creatinine.
A lung transplant recipient has a dry cough and desaturates on walking, with a nearly normal chest X-ray. What must be excluded?
Pneumocystis pneumonia, CMV pneumonitis and acute rejection. Chest CT, CMV PCR and early contact with the transplant team, who may need bronchoscopy.
A heart transplant recipient asks for the yellow fever vaccine before a trip to the eastern plains. What do you answer?
Yellow fever vaccine is live and contraindicated under immunosuppression. Refer to the transplant team for travel advice and the inactivated vaccines they recommend.
Elsewhere in DurgiPedia
- Transplant rejection: hyperacute, acute, chronic
- Immunosuppressants by mechanism (classes)
- Live vaccines: who should not receive them
- The lung in immunocompromise and transplant
- Heart transplantation and cardiac devices
- The skin of transplant and immunosuppressed patients
Connections
Educational content; it does not replace supervised training, your institution's protocols or a medical assessment. It contains no doses. In a real emergency, call the emergency number (123 in Colombia) or go to the nearest emergency department; for poisoning, contact the toxicology line (CIATOX in Colombia).
Sources: Transplant rejection (MedlinePlus, U.S. National Library of Medicine, 2026); Tacrolimus (MedlinePlus Drug Information, U.S. National Library of Medicine, 2026); Pneumocystis Pneumonia Basics (CDC, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
